FINLEY JOHN DAVID (Chief Financial Officer) exercised options at PALISADE BIO, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 3/12/2024ACC: 0001493152-24-009709
Officer· Chief Financial Officer
Since Apr 2021
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
5.56K acquired · 5.56K disposed
Non-Derivative Transactions1
Common Stock, par value $0.01
Direct
Shares
+5.56K
Price / share
—
Trade value
—
% of position
6.1%
3/11/2024
91.29K→96.85K
Total
Net shares
+5.56K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.01 Direct | 3/11/2024 | M · Option Exercise | +5.56K | — | — | 6.1% | 91.29K | 96.85K |
| Total | +5.56K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
5.56K shares
Shares
−5.56K
Strike price
Held after
50.02K
Exercisable
—
3/11/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock5.56K shares | 3/11/2024 | M · Option Exercise | −5.56K | — | 50.02K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock, par value $0.01
IndirectShares owned777.00
Total
777.00 indirect777.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.01 | 777.00 | Indirect |
| Total | 777.00 | 777.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported